Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $791.00 |
|---|---|
| Enterprise Value | $823,844.00 |
| Earnings per Share | $-0.21 |
| Beta | 2.47 |
| Outstanding Shares | 7,888,000 |
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 50.5 |
| Enterprise Value to EBIT | -0.55 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 3.91 |
| Debt to Equity | -5.51 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company’s products include Proteoderm, an anti-aging skin cream based on a proprietary and patent...